Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains.
The varicella-zoster virus (VZV) Oka vaccine strain (vOka) differs from the parental strain (pOka) at several amino acid positions, but the mutations responsible for the attenuation of vOka have not been clearly defined. The ORF0 of vOka carries some of the mutations. Although we found that the ORF0 of both strains was incorporated into virus particles, the C-terminal region of vOka ORF0 was presented on the virion surface and was N-glycosylated, suggesting that the mutation in vOka ORF0 changes it into a novel envelope glycoprotein. In a mutant virus in which pOka ORF0 was replaced by vOka ORF0, the molecular weight of ORF0 was altered, but the plaque size was not. In addition, a pOka recombinant virus lacking the hydrophobic domain of ORF0 grew equally well as the wild-type virus, indicating that the mutation in ORF0 is not by itself sufficient for the attenuation of the vOka virus.
Koshizuka
Tetsuo
T
Laboratory of Virology and Vaccinology, Division of Biomedical Research, National Institute of Biomedical Innovation, Ibaraki, Osaka 567-0085, Japan.
Ota
Megumi
M
Yamanishi
Koichi
K
Mori
Yasuko
Y
D002460:Cell Line; D006562:Herpes Zoster / Q000821:virology; D014645:Herpesvirus 3, Human / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity; D006801:Humans; D009154:Mutation; D016366:Open Reading Frames / Q000235:genetics* / Q000502:physiology; D011995:Recombination, Genetic; D014613:Vaccines, Attenuated / Q000235:genetics*; D014759:Viral Envelope Proteins / Q000235:genetics / Q000378:metabolism; D014765:Viral Vaccines / Q000235:genetics*; D014771:Virion / Q000378:metabolism
D014613:Vaccines, Attenuated; D014759:Viral Envelope Proteins; D014765:Viral Vaccines